Aktuelle Fragen des med.-wiss. Publikationswesens (Teil 2)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119][120][121]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. ↑ Guidelines for reporting statistics in journals published by the American Physiological Society. Am J Physiol Endocrinol Metab 287(2):E189-91 (2004) PMID 15271643
  2. ↑ Ten categories of statistical errors: a guide for research in endocrinology and metabolism. Am J Physiol Endocrinol Metab 286(4):E495-501 (2004) PMID 15010353
  3. ↑ Publishing in the journals of the APS: why are authors charged fees? Am J Physiol Endocrinol Metab 278(5):E757-8 (2000) PMID 10780929
  4. ↑ At jeopardy: the NIH as we know it. Arch Neurol 60(9):1191-2 (2003) PMID 12975281
  5. ↑ The Arthritis Research non-peer-review depository. Arthritis Res 2(1):1 (2000) PMID 11219388
  6. ↑ What journal citations teach us about rheumatic diseases. Arthritis Rheum 58(2 Suppl):S153-9 (2008) PMID 18240270
  7. ↑ Traditional publications: an endangered species? Arthritis Rheum 58(2 Suppl):S149-52 (2008) PMID 18240269
  8. ↑ Drug evaluation and approval process in the European Union. Arthritis Rheum 55(1):12-4 (2006) PMID 16463405
  9. ↑ A Food and Drug Administration primer. Arthritis Rheum 55(1):4-8 (2006) PMID 16463403
  10. ↑ New journal policy regarding registration of clinical trials. Arthritis Rheum 52(8):2243-7 (2005) PMID 16052548
  11. ↑ Open access, yes! Open excess, no! Blood 103(9):3257 (2004) PMID 15096439
  12. ↑ Removing the cloud from industry-sponsored, multicentered clinical trials. Blood 98(7):2001 (2001) PMID 11567981
  13. ↑ Access to the biomedical literature: a stand against coercion. Blood 97(8):2195-6 (2001) PMID 11290578
  14. ↑ Reporting clinical trials: full access to all the data. Brain 125(Pt 3):i-ii (2002) PMID 11872625
  15. ↑ Intuition and innumeracy. Cell Biol Educ 3(2):88-90 (2004) PMID 15257335
  16. ↑ Need for quality improvement in renal systematic reviews. Clin J Am Soc Nephrol 3(4):1102-14 (2008) PMID 18400967
  17. ↑ Commentary on "Influence of industry on renal guideline development". Clin J Am Soc Nephrol 2(2):211 (2007) PMID 17699413
  18. ↑ Translating guidelines into policy. Clin J Am Soc Nephrol 2(2):209-10 (2007) PMID 17699412
  19. ↑ Comments on the guideline debate. Clin J Am Soc Nephrol 2(2):208 (2007) PMID 17699411
  20. ↑ Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2(1):3-7; discussion 13-4 (2007) PMID 17699377
  21. ↑ Strategies for successful patient oriented research: why did I (not) get funded? Clin J Am Soc Nephrol 1(2):340-3 (2006) PMID 17699226
  22. ↑ The Cochrane collaboration and its possible impact on diabetes care. Diabetes Care 23(9):1217-8 (2000) PMID 10977007
  23. ↑ Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56 Suppl 1():1-113 (2007) PMID 17303614
  24. ↑ How Gut handles your manuscript. Gut 54(12):1667 (2005) PMID 16284280
  25. ↑ Retractions in Gut 10 years after publication. Gut 48(3):285-6 (2001) PMID 11171811
  26. ↑ Research misconduct. Gut 41(1):1-2 (1997) PMID 9274461
  27. ↑ How ghost-writing threatens the credibility of medical knowledge and medical journals. Haematologica 95(1):1-2 (2010) PMID 20065074
  28. ↑ Paying for open access. Haematologica 94(6):764 (2009) PMID 19483155
  29. ↑ Registration of clinical trials: a step forward but still a long path ahead. Haematologica 91(3):295-6 (2006) PMID 16531252
  30. ↑ Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Haematologica 91(3):293-5 (2006) PMID 16531251
  31. ↑ International Committee of Medical Journal Editors (ICMJE): Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. Haematologica 89(3):264 (2004) PMID 15020262
  32. ↑ Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease. Haematologica 86(11):1121-3 (2001) PMID 11694399
  33. ↑ Trials and tribulations of systematic reviews and meta-analyses. Hematology Am Soc Hematol Educ Program ():493-7 (2007) PMID 18024670
  34. ↑ Are there circumstances in which phase 2 study results should be practice-changing? Hematology Am Soc Hematol Educ Program ():489-92 (2007) PMID 18024669
  35. ↑ A guide to planning careers in hematology and oncology. Hematology Am Soc Hematol Educ Program ():499-506 (2001) PMID 11723001
  36. ↑ Quality of reports on randomized controlled trials conducted in Japan: evaluation of adherence to the CONSORT statement. Intern Med 48(5):307-13 (2009) PMID 19252352
  37. ↑ Uniform clinical trial registration policy for journals of kidney diseases, dialysis, and transplantation. J Am Soc Nephrol 16(4):837 (2005) PMID 15743992
  38. ↑ The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 15(2):411-9 (2004) PMID 14747388
  39. ↑ Randomized trial reporting in general endocrine journals: the good, the bad, and the ugly. J Clin Endocrinol Metab 93(10):3733-4 (2008) PMID 18842985
  40. ↑ Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab 93(10):3810-6 (2008) PMID 18583463
  41. ↑ A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93(3):666-73 (2008) PMID 18171699
  42. ↑ How to write an effective referee report. J Clin Invest 119(5):1058-60 (2009) PMID 19422091
  43. ↑ Publish or perish, but at what cost? J Clin Invest 118(7):2368 (2008) PMID 18596904
  44. ↑ How to write a scientific masterpiece. J Clin Invest 117(12):3599-602 (2007) PMID 18060016
  45. ↑ Payment of clinical research subjects. J Clin Invest 115(7):1681-7 (2005) PMID 16007244
  46. ↑ Responsible conduct in animal research. J Clin Invest 112(10):1456 (2003) PMID 14617743
  47. ↑ The physician-scientist: an essential--and fragile--link in the medical research chain. J Clin Invest 103(12):1621-6 (1999) PMID 10377167
  48. ↑ The clinical investigator: bewitched, bothered, and bewildered--but still beloved. J Clin Invest 99(12):2803-12 (1997) PMID 9185499
  49. ↑ Chance, concurrence, and clustering. Analysis of reviewers' recommendations on 1,000 submissions to the Journal of Clinical Investigation. J Clin Invest 93(5):1877-80 (1994) PMID 8182120
  50. ↑ The screening review system: fair or foul? J Clin Invest 93(5):1871-4 (1994) PMID 8182119
  51. ↑ Translating research into cancer molecular diagnostics and patents. J Clin Pathol 58(8):793-4 (2005) PMID 16049278
  52. ↑ Electronic publishing and internet learning. J Clin Pathol 55(12):881-2 (2002) PMID 12461043
  53. ↑ Guidelines on authorship: INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL EDITORS. J Clin Pathol 39(1):110 (1986) PMID 16811159
  54. ↑ Editorial: Authorships and acknowledgements. J Clin Pathol 31(4):299 (1978) PMID 16811108
  55. ↑ Funding free and universal access to Journal of Neuroinflammation. J Neuroinflammation 1(1):19 (2004) PMID 15485579
  56. ↑ Advanced online publication. J Neurol Neurosurg Psychiatry 76(6):759 (2005) PMID 15897491
  57. ↑ Reporting clinical trials: full access to all the data. J Neurol Neurosurg Psychiatry 72(2):143 (2002) PMID 11796759
  58. ↑ Giving something back to the authors. J Neurol Neurosurg Psychiatry 67(4):419 (1999) PMID 10486381
  59. ↑ Archie Cochrane's challenge: can periodically updated reviews of all randomised controlled trials relevant to neurology and neurosurgery be produced? J Neurol Neurosurg Psychiatry 57(5):529-33 (1994) PMID 8201319
  60. ↑ The NIH Public Access Policy. J Neurosci 28(16):4109 (2008) PMID 18417688
  61. ↑ Open access and the future of the scientific research article. J Neurosci 26(40):10079-81 (2006) PMID 17021163
  62. ↑ Reinventing the biomedical journal. J Neurosci 26(39):9837-8 (2006) PMID 17005847
  63. ↑ Will research sharing keep pace with the Internet? J Neurosci 26(37):9349-51 (2006) PMID 16971518
  64. ↑ Bias in the research literature and conflict of interest: an issue for publishers, editors, reviewers and authors, and it is not just about the money. J Psychiatry Neurosci 34(6):412-7 (2009) PMID 19949717
  65. ↑ Journal of Psychiatry and Neuroscience peer review process, with advice for authors. J Psychiatry Neurosci 33(1):7-9 (2008) PMID 18197266
  66. ↑ Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology. J Psychiatry Neurosci 31(1):13-20 (2006) PMID 16496031
  67. ↑ Ethical conduct of journal editors. J Psychiatry Neurosci 29(5):334-6 (2004) PMID 15486604
  68. ↑ The physician-scientist in Canadian psychiatry. J Psychiatry Neurosci 29(1):49-56 (2004) PMID 14719050
  69. ↑ Peer review of manuscripts: theory and practice. J Psychiatry Neurosci 28(5):327-30 (2003) PMID 14517575
  70. ↑ Risk in research--from the Nuremberg Code to the tri-council code: implications for clinical trials of psychotropic drugs. J Psychiatry Neurosci 23(3):149-55 (1998) PMID 9595888
  71. ↑ Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper. JAMA 280(3):227-8 (1998) PMID 9676663
  72. ↑ Financial interest and its disclosure in scientific publications. JAMA 280(3):225-6 (1998) PMID 9676662
  73. ↑ Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA 280(3):222-4 (1998) PMID 9676661
  74. ↑ What are the factors determining authorship and the order of the authors' names? A study among authors of the Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine). JAMA 280(3):217-8 (1998) PMID 9676659
  75. ↑ Alcohol screening questionnaires in women: a critical review. JAMA 280(2):166-71 (1998) PMID 9669791
  76. ↑ Privacy and confidentiality in the publication of pedigrees: a survey of investigators and biomedical journals. JAMA 279(22):1808-12 (1998) PMID 9628712
  77. ↑ Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol Dial Transplant 23(1):56-61 (2008) PMID 18032412
  78. ↑ A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance. Nephrol Dial Transplant 23(1):52-5 (2008) PMID 17977874
  79. ↑ Trial registry policy: common editorial statement a uniform clinical trial registration policy for journals of kidney diseases, dialysis and transplantation. Nephrol Dial Transplant 20(4):691 (2005) PMID 15772264
  80. ↑ Stopping a medical research project for financial reasons. Nephrol Dial Transplant 18(10):1982-3 (2003) PMID 13679470
  81. ↑ How is the annual congress of your society managed? (Reflection on the ethics and finances of medical congresses). Nephrol Dial Transplant 13(9):2207-9 (1998) PMID 9761498
  82. ↑ Honesty in publication. Nephrol Dial Transplant 13(6):1365-7 (1998) PMID 9641161
  83. ↑ Systematic reviews and their roles in promoting evidence-based medicine in renal disease. Nephrol Dial Transplant 11(12):2398-401 (1996) PMID 9017610
  84. ↑ The quest for market exclusivity in biotechnology: navigating the patent minefield. NeuroRx 2(4):572-8 (2005) PMID 16489366
  85. ↑ Evidence from clinical trials: can we do better? NeuroRx 1(3):363-71 (2004) PMID 15717039
  86. ↑ Policy-relevant research: when does it matter? NeuroRx 1(3):356-62 (2004) PMID 15717038
  87. ↑ Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx 1(3):341-7 (2004) PMID 15717036
  88. ↑ From evidence to action. NeuroRx 1(3):331-40 (2004) PMID 15717035
  89. ↑ Evidence from biomarkers and surrogate endpoints. NeuroRx 1(3):323-30 (2004) PMID 15717034
  90. ↑ FDA: evidentiary standards for drug development and approval. NeuroRx 1(3):307-16 (2004) PMID 15717032
  91. ↑ Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 1(2):284-94 (2004) PMID 15717029
  92. ↑ The industrialization of the hospitals and the unhappiness of the physicians. Perit Dial Int 11(2):107, 109 (1991) PMID 1854865
  93. ↑ A 30 year perspective of the quality of evidence published in 25 clinical journals: signs of change? Postgrad Med J 82(968):397-9 (2006) PMID 16754709
  94. ↑ Clinical application of findings of clinical trials and systematic reviews. Postgrad Med J 78(917):129-30 (2002) PMID 11884692
  95. ↑ Training of junior doctors: the responsibility of consultants and trainers. Postgrad Med J 77(914):745-6 (2001) PMID 11723310
  96. ↑ Education and training in internal medicine in Europe. Postgrad Med J 77(913):727-31 (2001) PMID 11677285
  97. ↑ Getting our journals to developing countries. Postgrad Med J 77(911):554-5 (2001) PMID 11524510
  98. ↑ Learning to teach. Postgrad Med J 77(908):361-2 (2001) PMID 11375447
  99. ↑ Peer review in health sciences. Postgrad Med J 76(902):815 (2000) PMID 11085789
  100. ↑ Evidence based medicine overviews, bulletins, guidelines, and the new consensus. Postgrad Med J 76(897):383-9 (2000) PMID 10878193
  101. ↑ Clinical guidelines: development, implementation, and effectiveness. Postgrad Med J 71(831):3-9 (1995) PMID 7708589
  102. ↑ Identifying low-quality preclinical studies. Stroke 39(10):2697-8 (2008) PMID 18635834
  103. ↑ Searching additional databases except PubMed are necessary for a systematic review. Stroke 39(8):e139; author reply e140 (2008) PMID 18583557
  104. ↑ Nonconventional clinical trial designs: approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost. Stroke 38(2 Suppl):804-8 (2007) PMID 17261743
  105. ↑ Frequency and determinants of nonpublication of research in the stroke literature. Stroke 37(10):2588-92 (2006) PMID 16931779
  106. ↑ Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Stroke 36(4):924-5 (2005) PMID 15800253
  107. ↑ Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35(5):1203-8 (2004) PMID 15060322
  108. ↑ Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome. Stroke 35(5):1216-24 (2004) PMID 15031455
  109. ↑ Meta-analysis reported incompatible statistics and omitted pertinent studies. Stroke 35(4):e79-80; author reply e79-80 (2004) PMID 15001792
  110. ↑ Conducting stroke research with an exception from the requirement for informed consent. Stroke 34(5):1317-23 (2003) PMID 12663878
  111. ↑ Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials. Stroke 34(4):1041-5 (2003) PMID 12649514
  112. ↑ Reporting clinical trials: full access to all the data. Stroke 32(12):2734 (2001) PMID 11739964
  113. ↑ Authors should be accurate when describing study design. Stroke 32(4):1048-9 (2001) PMID 11283410
  114. ↑ Reports of randomized trials in acute stroke, 1955 to 1995. What proportions were commercially sponsored? Stroke 30(10):1995-8 (1999) PMID 10512897
  115. ↑ An observation: role of the M.D., Ph.D. in science. Toxicol Sci 49(2):165 (1999) PMID 10416261
  116. ↑ Baishideng's century goal: editing and publishing high-quality articles. World J Gastroenterol 15(31):3841-4 (2009) PMID 19701962
  117. ↑ Concentrations and characteristics of organochlorine pesticides in aquatic biota from Qiantang River in China. Environ Pollut 151(1):190-9 (2008) PMID 17499409
  118. ↑ Who owns the data? Hepatology 40(6):1237 (2004) PMID 15558736
  119. ↑ Redundant publication: a form of reader abuse. Hepatology 24(1):268-9 (1996) PMID 8707273
  120. ↑ [Leukocytosis and the fibrinolytic activity of the blood in patients with leukemia] Probl Gematol Pereliv Krovi 20(10):39-42 (1975) PMID 1060059
  121. ↑ WTP and WTA: do people think differently? Soc Sci Med 65(5):946-57 (2007) PMID 17499410

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Aktuelle_Fragen_des_med.-wiss._Publikationswesens_(Teil_2)&oldid=44271“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway